$ABBV AbbVie Reports Second-Quarter 2021 Financial Results

on July 30, 2021 News and Tags: , , , with 0 comments
Time:
7:44 AM
Symbol:
ABBV
Source:
PR Newswire
Read more

$ABBV DALVANCE® (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients

on July 23, 2021 News and Tags: , , , with 0 comments
Time:
12:37 PM
Symbol:
ABBV
Source:
PR Newswire
Read more

$ABBV Venetoclax (VENCLEXTA®) Granted US FDA Breakthrough Therapy Designation (BTD) in Higher Risk Myelodysplastic Syndrome (MDS)

on July 21, 2021 News and Tags: , , , with 0 comments
Time:
1:00 AM
Symbol:
ABBV
Source:
PR Newswire
Read more

$ABBV Venetoclax (VENCLEXTA®) Granted US FDA Breakthrough Therapy Designation (BTD) in Higher Risk Myelodysplastic Syndrome (MDS)

on July 20, 2021 News and Tags: , , , with 0 comments
Time:
1:00 AM
Symbol:
ABBV
Source:
PR Newswire
Read more

$ABBV AbbVie Provides Update Regarding RINVOQ® (upadacitinib) for the Treatment of Moderate to Severe Atopic Dermatitis in the U.S.

on July 16, 2021 News and Tags: , , , with 0 comments
Time:
8:30 AM
Symbol:
ABBV
Source:
PR Newswire
Read more

$ABBV Collaboration Between AbbVie, Biogen and Pfizer Creates World’s Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease

on July 8, 2021 News and Tags: , , , , , , , , , , , with 0 comments
Time:
4:06 PM
Symbol:
ABBV
Source:
GlobeNewswire News Releases
Read more

$ABBV AbbVie Gastroenterology Pipeline to be Featured at the 16th Congress of European Crohn’s and Colitis Organisation (ECCO)

on June 28, 2021 News and Tags: , , , with 0 comments
Time:
8:45 AM
Symbol:
ABBV
Source:
PR Newswire
Read more

$ABBV CHMP Recommends Approval of RINVOQ® (upadacitinib) for the Treatment of Atopic Dermatitis

on June 25, 2021 News and Tags: , , , with 0 comments
Time:
2:30 AM
Symbol:
ABBV
Source:
PR Newswire
Read more

$ABBV AbbVie Declares Quarterly Dividend

on June 17, 2021 News and Tags: , , , with 0 comments
Time:
6:29 PM
Symbol:
ABBV
Source:
PR Newswire
Read more

$ABBV Zhongchao Inc. Partners with a Subsidiary of AbbVie Inc. (NYSE: ABBV) for Medical Education Services

on June 16, 2021 News and Tags: , , , , , , , with 0 comments
Time:
6:30 AM
Symbol:
ABBV
Source:
PR Newswire
Read more

$ABBV IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Combination Shows Superior Progression-Free Survival Compared to Chlorambucil Plus Obinutuzumab in First-line Chronic Lymphocytic Leukemi

on June 12, 2021 News and Tags: , , , with 0 comments
Time:
7:02 AM
Symbol:
ABBV
Source:
PR Newswire
Read more

$ABBV New Data Shows AbbVie’s VENCLYXTO®/VENCLEXTA® Fixed Duration Combination Demonstrates Sustained Progression-Free Survival in Chronic Lymphocytic Leukemia Patients after Three Years off Treatment

on June 11, 2021 News and Tags: , , , with 0 comments
Time:
1:03 AM
Symbol:
ABBV
Source:
PR Newswire
Read more

$ABBV New Data Shows AbbVie’s VENCLYXTO®/VENCLEXTA® Fixed Duration Combination Demonstrates Sustained Progression-Free Survival in Chronic Lymphocytic Leukemia Patients after Three Years off Treatment

on June 10, 2021 News and Tags: , , , with 0 comments
Time:
1:03 AM
Symbol:
ABBV
Source:
PR Newswire
Read more

$ABBV Caraway Therapeutics Establishes Collaboration with AbbVie to Develop Novel Small Molecule Therapeutics for Parkinson’s Disease and Other Related Disorders

on June 9, 2021 News and Tags: , , , with 0 comments
Time:
6:00 AM
Symbol:
ABBV
Source:
Business Wire News Releases
Read more

$ABBV CAPTIVATE Study Shows an IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Chemotherapy-Free Combination Has Potential to Provide Remission After Fixed-Duration Treatment for Chronic Lymp

on June 7, 2021 News and Tags: , , , with 0 comments
Time:
11:30 AM
Symbol:
ABBV
Source:
PR Newswire
Read more

$ABBV Results from IMBRUVICA® (ibrutinib) RESONATE-2 Study Provide Up to Seven Years of Progression-Free and Overall Survival Data in First-Line Chronic Lymphocytic Leukemia (CLL)

on June 4, 2021 News and Tags: , , , with 0 comments
Time:
9:00 AM
Symbol:
ABBV
Source:
PR Newswire
Read more

$ABBV AbbVie to Present Analysis Evaluating Continuous RINVOQ® (upadacitinib) Treatment in Psoriatic Arthritis for More Than One Year at EULAR 2021 Virtual Congress

on June 2, 2021 News and Tags: , , , with 0 comments
Time:
7:30 AM
Symbol:
ABBV
Source:
PR Newswire
Read more

$ABBV AbbVie to Present at Bernstein’s 37th Annual Strategic Decisions Conference

on May 26, 2021 News and Tags: , , , with 0 comments
Time:
8:15 AM
Symbol:
ABBV
Source:
PR Newswire
Read more

$ABBV AbbVie Presents New Late-Breaking Data Analyses Showing Risankizumab (SKYRIZI®) Achieves Clinical Remission and Endoscopic Response at Week 12 in Patients with Moderate to Severe Crohn’s Disease

on May 24, 2021 News and Tags: , , , with 0 comments
Time:
9:15 AM
Symbol:
ABBV
Source:
PR Newswire
Read more

$ABBV Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio

on May 10, 2021 News and Tags: , , , , , , , with 0 comments
Time:
8:30 AM
Symbol:
ABBV
Source:
PR Newswire
Read more